Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Hyperlipidemia, Familial Combined

• "Phospholipovit" vs Placebo in Patients With Combined Hyperlipidemia
• The Efficacy and Safety of JS002 PFS and AI in Patients With Primary Hypercholesterolemia and Mixed Hyperlipidemia
• Phase 3 Study to Evaluate the Efficacy and Safety of Omega-3-acids Ethylesters 90 in Type Ⅱb Hyperlipidemia
• A Pilot Study to Evaluate the Lipid Effects of TRIA-662
• Comparison of the Efficacy and Safety of AtorVastatin mOnotherapy vs. Combination Atorvastatin/Fenofibric Acid
• Efficacy and Safety of Fenofibrate Added on to Atorvastatin Compared With Atorvastatin
• A Study to Evaluate the Effects of Laropiprant on the Antiplatelet Effects of Clopidogrel and Aspirin in Combination (MK-0524A-114)(COMPLETED)
• Comparison of High-Dose Rosuvastatin Versus Low Statin Dose Plus Fenofibrate Versus Low Statin Dose Plus Niacin in the Treatment of Mixed Hyperlipidemia
• Phase 2 Dose-Ranging Efficacy and Safety Trial of SCH 900271 in Participants With Primary Hypercholesterolemia or Mixed Hyperlipidemia (P05675)
• Study to Compare Welchol and TriCor to TriCor Alone in Patients With High Cholesterol
• Efficacy of Ezetimibe/Simvastatin 10/20 mg and MK0524A (1-2 g/Day) in Mixed Hyperlipidemia and Two or More Risk Factors
• Effect of Rosuvastatin on Triglyceride Levels in Mexican Hypertriglyceridemic Patients
• Effects of FXR Activation on Hepatic Lipid and Glucose Metabolism
• A Study to Evaluate Daily Pravastatin, Fenofibrate or Pravafen in the Treatment of Combined Hyperlipidemia
• Efficacy Study of Extended-Release Niacin/Lovastatin Versus Usual Care
• Lipid Efficacy and Safety in Participants With Mixed Hyperlipidemia (MK-0524B-024)
• To Evaluate Ezetimibe/Simvastatin and Niacin (Extended Release Tablet) in Patients With Type IIa or Type IIb Hyperlipidemia (0653A-091)(COMPLETED)
• Lipid Efficacy Study (0524B-022)(COMPLETED)
• Lipid Efficacy/Tolerability Study (0524A-020)
• Carotid B-mode Ultrasound Study to Compare Anti-Atherosclerotic Effect of Torcetrapib/Atorvastatin to Atorvastatin.
• A Study to Evaluate an Investigational Drug in Patients With Mixed Hyperlipidemia (0653A-071)(COMPLETED)
• Study of Ezetimibe and Fenofibrate in Patients With Mixed Hyperlipidemia (0653-036)(COMPLETED)
• Two Investigational Drugs in Patients With Mixed Hyperlipidemia (0653-036)